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Organochlorine (OC) pesticides, a class of 
hydrocarbon compounds characterized by 
their cyclic structure, number and position of 
chlorine atoms, and low volatility, were widely 
used in agriculture and pest control after they 
were introduced in the 1940s. They include 
hexachlorocyclohexane (HCH) isomers, DDT 
and its analogs, and cyclodienes. Because of 
their nature of persistence in the environment, 
bioaccumulation in the food chain, and pos-
sible health effects, the U.S. Environmental 
Protection Agency restricted and banned the 
use of most of OC pesticides during the 1970s 
and 1980s. Although OC pesticides are rarely 
used in the United States today, measurable 
amounts of OC pesticides or their metabo-
lites can still be found in human tissues in the 
United States. Moreover, OC pesticides con-
tinue to be heavily used in some developing 
countries, primarily for mosquito and malaria 
control (Turusov et al. 2002). Thus, the health 
effects of OC exposure remain an important 
global public health concern.
Evidence from experimental assays suggests 
that a number of OC pesticides demonstrate 
weak estrogenic or antiestrogenic effects (Soto 
et al. 1995). These chemicals interfere with the 
function of the endocrine system by mimick-
ing a hormone, blocking the effects of normal, 
endogenous hormones, or by altering or modi-
fying the synthesis, metabolism, or transport of 
hormones (Soto et al. 1995). It is believed that 
these compounds may act as a tumor promoter 
through hormone-mediated effects (Hansen 
and Matsumura 2001). Some epidemiologic 
studies have linked OC pesticides with sev-
eral hormone-related cancers including breast 
cancer (Calle et al. 2002), prostate cancer 
(Mills and Yang 2003), endometrial cancer 
(Weiderpass et al. 2000), and testicular cancer 
(Biggs et al. 2008). However, findings from 
epidemiologic studies have not been consistent, 
particularly for breast and prostate cancer. 
The primary source of exposure to 
OC pesticides in the general population is 
believed to be through diet via consumption 
of milk, fish, and meat (Toppari et al. 1996). 
Additional exposure pathways include dust, 
air, and soil. Measurement of OC pesticide 
exposure is a complex and challenging process 
because of the multiple pathways of expo-
sure. Biomonitoring of exposure is a useful 
tool for assessing exposure to OC pesticides. 
Specifically, measurement of OC pesticides, 
their metabolites, or reaction product in 
biological media such as blood or urine is 
an effective way to determine the extent of 
chronic exposure to these chemicals (Barr 
2008). In the National Health and Nutrition 
Examination Survey (NHANES), a sub-
sample of one-third of participants ≥ 12 years 
of age was selected and was measured for 
the concentrations of OC pesticides or their 
metabolites in blood in each biannual data 
cycle. In addition, information on personal   
medical conditions including physician- 
diagnosed site-specific cancers was collected 
using a questionnaire. In this study, we used 
the 1999–2004 NHANES data to evalu-
ate the relationships between lipid-adjusted 
serum concentrations of OC pesticides and 
breast cancer as well as prostate cancer. 
Materials and Methods 
Study population. Data from the NHANES 
survey cycles conducted in 1999–2000, 
2001–2002, and 2003–2004 were obtained 
online (CDC 2009d). During these three 
data collection cycles, blood samples from 
the one-third of the participants ≥ 12 years 
of age were collected and measured for serum 
concentrations of several OC pesticides or 
their metabolites. For each NHANES data 
cycle, this random subsample is representa-
tive of the noninstitutionalized U.S. civilian 
population. Participants < 20 years of age 
were not asked for information about chronic 
medical conditions including a diagnosis of 
site-specific cancer. Consequently, this analy-
sis included only participants who were both 
tested for blood OC pesticides and asked for 
information about personal medical condi-
tions. A total of 1,475 participants for the 
1999–2000 cycle, 1,693 participants for the 
2001–2002 cycle, and 1,585 participants for 
the 2003–2004 cycle were eligible for analysis 
of the associations of breast cancer as well as 
prostate cancer and OC pesticide exposure. 
Furthermore, individuals with other types 
of cancer were excluded from this analysis. 
Finally, the final sample size varied because of 
missing values of the dependent variable, the 
exposures, and the selected covariates. This 
study was conducted in conformity with all 
applicable requirements of the United States 
and/or international regulations of research 
on human subjects. The research protocol was 
reviewed and approved by the University of 
Florida Institutional Review Board. 
OC pesticide measurements. OC pesticides 
were measured in serum by high-resolution 
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Ba c k g r o u n d: Organochlorine (OC) pesticides are a group of environmental endocrine disruptors 
that may be associated with an increased risk for hormone-related cancers including cancers of the 
breast and prostate. However, epidemiologic evidence is limited and inconsistent.
oBjectives a n d m e t h o d s : We used 1999–2004 National Health and Nutrition Examination 
Survey data to examine associations between serum concentrations of OC pesticides and prostate 
and breast cancers.
re s u l t s: After adjustment for other covariates, serum concentrations of β-hexachlorocyclohexane 
(HCH) (p for trend = 0.02), trans-nonachlor (p for trend = 0.002), and dieldrin (p for trend = 0.04) 
were significantly associated with the risk of prevalent prostate cancer. Adjusted odds ratios for the 
second and third tertiles of detectable values were 1.46 [95% confidence interval (CI), 0.52–4.13] and 
3.36 (95% CI, 1.24–9.10) for β-HCH; 5.84 (95% CI, 1.06–32.2) and 14.1 (95% CI, 2.55–77.9) for 
trans-nonachlor; and 1.06 (95% CI, 0.30–3.73) and 2.74 (95% CI, 1.01–7.49) for dieldrin compared 
with concentrations in the lowest tertile or below the limit of detection. However, there was no posi-
tive association between serum concentrations of OC pesticides and breast cancer prevalence.
co n c l u s i o n: Although further study is necessary to confirm these findings, these results suggest 
that OC pesticide exposures may have a significant effect on cancer risk. Efforts to reduce worldwide 
OC use are warranted.
key w o r d s : cancer, endocrine disruptors, organochlorine pesticides, pesticide, prostate cancer. 
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gas chromatography/isotope-dilution high-
resolution mass spectrometry. Blood was col-
lected in red-top Vacutainers, which were 
placed upright in a rack to allow blood to clot 
at room temperature for 20–30 min. Serum 
was collected and frozen within 1.5 hr after 
the specimen was collected. Each analytical 
run consisted of nine unknown specimens, 
one method blank, and two quality control 
samples. The limit of detection (LOD) for 
each analyte was calculated correcting for sam-
ple weight and recovery. In addition, the total 
lipid content of each specimen was estimated 
from its total cholesterol and triglycerides val-
ues using a summation method. Analytical 
results for OC pesticides are reported on a 
lipid-adjusted basis (nanograms per gram or 
parts per billion). The lipid-adjusted concen-
tration of an analyte is given by
Clipid adjusted = [CONC/TL] × 102.6,  [1]
where CONC is the concentration of an 
analyte in a sample as weight per gram of 
sample, and TL (total lipid) = (2.27 × total 
cholesterol mg/dL + triglycerides + 62.3). The 
details of the laboratory protocol are avail-
able online (CDC 2006, 2009a, 2009b). Ten 
serum OC pesticides or their metabolites were 
meas  ured in these three NHANES data cycles   
(1999–2000, 2001–2002, and 2003–2004). 
These 10 biomarkers included hexachloro-
benzene, β-HCH, G-HCH, p,p´-DDE 
(dichloro  diphenyldichloroethylene), 
p,p´-DDT (dichloro  diphenyltrichloroethane), 
o,p´-DDT, oxychlordane, trans-nonachlor, 
heptachlor epoxide, and mirex. The other 
three OC pesticides including aldrin, dieldrin, 
and endrin were measured only in NHANES 
2001–2002 and NHANES 2003–2004 data 
cycles. To minimize the nondifferential meas-
ure  ment error among those below the LOD, 
we selected the OC pesticides for which at 
least 50% of study subjects had serum con-
centrations above the LOD. In our analy-
ses, the selected chemicals include β-HCH, 
p,p´-DDE, oxychlordane, trans-nonachlor, 
heptachlor epoxide, and dieldrin. Table 1 
presents the information regarding the num-
ber of missing values and the value range for 
each selected OC pesticide in each data cycle. 
Covariates. Covariates related to the 
develop  ment of hormone-related cancers were 
selected and controlled for while evaluating 
the associations between exposure to OC 
pesticides and cancers. Participants’ demo-
graphic information such as age (< 65 years 
vs. ≥ 65 years of age), sex, race/ethnicity (non-
Hispanic white, non-Hispanic black, and oth-
ers that included Mexican Americans, other 
Hispanics, other races/multiracial individuals), 
education (> high school, high school, < high 
school), marital status (yes/no), poverty/ 
income ratio (< 1.0, 1.0–2.0, or > 2.0), and 
lifestyle factors such as cigarette smoking 
(yes/no) and alcohol drinking (yes/no) were 
extracted from the personal interview ques-
tionnaire. Other covariates such as body mass 
index (BMI; < 25.0, 25–29, or ≥ 30) and time 
since cancer diagnosis, which was estimated 
by subtracting age at cancer diagnosis from 
age at survey, were also selected. Considering 
potential temporal trend of OC pesticides in 
the U.S. population, data cycle (1999–2000, 
2001–2002, 2003–2004) was also included as 
a covariate in the analysis. 
For breast cancer, additional covariates 
of reproductive health such as age at menar-
che (≤ 12, 13–15, and ≥ 16 years), meno-
pausal status (yes vs. no), parity (nulliparous, 
1, 2, 3, and ≥ 3 births), age at first full-term 
birth or nulliparity (< 25 years, 25–29 years, 
≥ 30 years, or nulliparity), ever breast-fed child 
(yes vs. no), oral contraceptive use (current, 
ever, never), and ever used hormone replace-
ment therapy (yes vs. no) were also examined. 
Cancer outcomes. Medical conditions 
were collected using the NHANES question-
naire. The following questions were used to 
ascertain individual cancer status: “[Have 
you/Has SP] ever been told by a doctor or 
other health professional that [you/s/he] had 
cancer or a malignancy of any kind?” and if 
yes, “What kind of cancer is it?” According 
to the questions, the individual was asked to 
report physician-diagnosed cancers. There was 
no further validation of the cancer diagnosis 
in these data. In this analysis, individuals who 
reported breast cancer or prostate cancer were 
selected as the case group. Other types of can-
cers were excluded from this analysis. 
Data analyses. All statistical analy-
ses were performed using SAS 9.1 software 
(SAS Institute Inc., Cary, NC) survey proce-
dures, which account for the complex sam-
pling design used in NHANES. The sample 
weights, stratification, and clustering design 
variables were incorporated into all SAS sur-
vey procedures to ensure the correct estima-
tion of sampling error. A 6-year subsample 
weight was calculated for the combined 
1999–2004 data by following the NHANES 
analytic and reporting guidelines and assign-
ing one-third of the 2-year OC pesticides sub-
sample weight (WTSB2YR) for 2003–2004 
if a participant was sampled in 2003–2004 
and merging it with two-thirds of the 4-year 
1999–2002 OC pesticides subsample weight 
(WTSPO4YR) for those sampled in 1999–
2002 (CDC 2009c). We used this calculated 
weight to analyze the merged 6-year data of 
NHANES 1999–2004 data. Because dieldrin 
was measured only in the NHANES 2001–
2004 data cycles, a 4-year subsample weight 
was calculated for the combined 2001–2004 
data by assigning half of the 2-year OC pes-
ticides subsample weight (WTSB2YR) for 
2003–2004 if a participant was sampled in 
2003–2004 and merging it with half of the 
2-year 2001–2002 OC pesticides subsample 
weight (WTSPO2YR) for those sampled in 
2001–2002.
Descriptive statistics such as two-sided 
Student t-tests and Wald chi-square analy-
ses were also performed, where appropriate. 
Logistic regression models were used to evalu-
ate the associations between exposure to OC 
pesticides and hormone-related cancers, breast 
cancer or prostate cancer. For each OC pesti-
cide, the reference group is defined as those 
participants whose serum concentrations are 
Table 1. Lipid-adjusted serum concentration of OC pesticides in 1999–2004 NHANES adult participants ≥ 20 years of age.  
Chemical
1999–2000 cycle (n = 1,475) 2001–2002 cycle (n = 1,693) 2003–2004 cycle (n = 1,585)
No. 
(missing)
Percent 
≥ LOD
Value range 
(ng/g)
No. 
(missing)
Percent 
≥ LOD
Value range 
(ng/g)
No. 
(missing)
Percent 
≥ LOD
Value range 
(ng/g)
Hexachlorobenzene 1,111 (364) 26 12.4–381.0 1,530 (163) 7.52 3.3–241.0 1,373 (212) 0.07 1.55–174.0
β-HCH 1,240 (235) 83.23 1.46–766.36 1,533 (160) 72.74 1.41–3500.0 1,370 (215) 79.56 0.90–2850.0
λ-HCH 1,139 (336) 3.95 1.6–127.0 1,522 (171) 1.12 0.4–73.3 1,367 (218) 0.66 0.35–304.0
p,p´-DDE 1,278 (197) 99.92 6.58–27900.0 1,540 (153) 99.94 3.75–24200.0 1,368 (217) 99.85 1.56–22900.0
p,p´-DDT 1,002 (473) 43.01 3.25–3450.0 1,549 (144) 38.67 2.33–2280.0 1,370 (215) 81.75 0.90–676.0
o,p´-DDT 1,002 (473) 1.1 2.2–116.0 1,523 (170) 2.1 0.7–194.0 1,358 (227) 7.51 0.49–223.0
Oxychlordane 998 (477) 82.36 2.3–218.0 1,497 (196) 81.96 1.7–289.0 1,383 (202) 87.85 1.06–159.0
trans-Nonachlor 1,269 (206) 91.57 2.3–331.0 1,528 (165) 89.20 1.7–834.0 1,366 (219) 96.19 1.34–355.0
Heptachlor epoxide 951 (524) 52.58 2.3–912.0 1,518 (175) 60.21 1.4– 181.0 1,371 (214) 66.67 1.10–154.0
Mirex 1,194 (281) 13.32 1.6–22.0 1,529 (164) 33.75 1.1–2960.0 1,359 (226) 49.45 0.49–166.0
Aldrin – – – 1,519 (174) 0.26 0.4–8.5 1,358 (227) 0.15 0.35–58.1
Dieldrin – – – 1,443 (250) 64.73 1.9– 670.0 1,365 (220) 90.70 1.20–448.0
Endrin – – – 1,457 (236) 0.14 0.4–11.7 1,286 (299) 0.16 0.35–6.10Xu et al.
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less than the LOD, and subjects with detect-
able values were categorized by cutoff points 
of 33rd and 67th percentile values, which 
were calculated only among those with values 
above the LOD in the whole study popula-
tion including both cases and noncases. If 
there were no cancer cases or a small num-
ber of cancer cases (≤ 5 cases) in the refer-
ence group, subjects within the first tertile of 
detectable values were also included in the 
reference. We used the Akaike Information 
Criterion (AIC) to determine the best-fitting 
model. If two models were nested models, 
the more parsimonious model was selected 
if the χ2 difference was not significant based 
on AIC. Otherwise, the smaller AIC was used 
as indicator of the better fit. Moreover, we 
proposed several models adjusting for differ-
ent sets of covariates to examine the associa-
tions between OC pesticides and cancer risk 
to determine how robust the results were. 
Specifically, age-adjusted associations between 
exposure to individual chemicals and breast 
cancer as well as prostate cancer were cal-
culated. Furthermore, multivariate logistic 
regression was used to examine these asso-
ciations, with adjustment for known risk fac-
tors and potential confounders. Odds ratios 
(ORs) and 95% confidence intervals (CIs) 
were reported.
Results
The sample of 4,237 participants included 
4,109 individuals without cancer and 128 
cancer cases including 63 breast cancer cases 
and 65 prostate cancer cases. Relationships 
between all 21 pairwise combinations of 
six OC pesticides as well as time since can-
cer diagnosis are presented in Table 2, with 
results of the Spearman rank correlation tests. 
The results indicated that significant correla-
tions exist between all OC pesticides pairwise 
combinations. The Spearman rank correla-
tion coefficients ranged from 0.38 to 0.91. 
Oxychlordane was highly correlated with 
trans-nonachlor (0.91), heptachlor epoxide 
(0.65) and β-HCH (0.61). β-HCH was also 
highly correlated with p,p´-DDE (0.73). Time 
since cancer diagnosis was not correlated with 
any of the OC pesticides, with correlation 
coefficients ranging from –0.14 to 0.20.
Table 3 describes the relationships 
between selected characteristics and OC 
pesticides among the study population. Age 
was significantly associated with presence of 
OC pesticides. Individuals in the older age 
group had significantly higher concentrations 
of OC pesticides than those in the younger 
group. The percentages in the third tertiles 
of OC pesticides for younger (< 65 years 
of age) versus older (≥ 65 years) are 10.4% 
versus 51.4% for β-HCH; 16.0% versus 
48.7% for p,p´-DDE; 12.4% versus 68.1% 
for oxychlordane; 15.7% versus 65.6% for 
trans-  nonachlor; 12.5% versus 39.2% for 
heptachlor epoxide; and 18.4% versus 49.4% 
for dieldrin, respectively. In addition, lower 
education, higher BMI, and being a former 
smoker were significantly associated with 
Table 2. Spearman correlations (no. of samples) between OC pesticides/metabolites as well as time since cancer diagnosis in 1999–2004 NHANES adult partici-
pants ≥ 20 years of age. 
  β-HCH  p,p´-DDE Oxychlordane trans-Nonachlor Heptachlor epoxide Dieldrin   Time since cancer diagnosisa
β-HCH 1.0 0.73* (3,841)  0.63* (3,569) 0.61* (3,822) 0.58* (3,549) 0.43* (2,594) 0.09 (107)
p,p´-DDE — 1.0  0.53* (3,587) 0.56* (3,867) 0.44* (3,561) 0.38* (2,605) –0.02 (106)
Oxychlordane — — 1.0 0.91* (3,578) 0.65* (3,540) 0.53* (2,569) 0.20 (97)
trans-Nonachlor — — — 1.0 0.64* (3,556) 0.55* (2,588) 0.04 (104)
Heptachlor epoxide — — — — 1.0 0.67* (2,583) –0.10 (95)
Dieldrin — — — — — 1.0 –0.14 (73)
Time since cancer diagnosis — — — — — — 1.0
aCorrelations between survival time (years) and OC pesticides among breast and prostate cancer cases. *p < 0.05. 
Table 3. Relationships between selected characteristics and OC pesticides [no. (%)]. 
Education
Age (years) Race < High High > High Poverty/ income ratio
Chemical (%) < 65 ≥ 65 p-Value NHW NHB Others p-Value  school school  school p-Value < 1.0 1.0–2.0 > 2.0 p-Value
β-HCH
< LOD 852 (30.7) 25 (2.9) < 0.001 478 (27.1) 242 (35.7) 157 (18.5) < 0.001 175 (19.6) 223 (27.6) 476 (28.5) < 0.001 154 (32.0) 214 (27.8) 446 (25.4) < 0.001
< 33 903 (35.4) 74 (8.4) 555 (33.4) 197 (28.4) 225 (24.9) 232 (24.4) 220 (30.0) 525 (34.6) 146 (28.1) 185 (25.6) 571 (34.7)
33–67 702 (23.5) 324 (37.3) 527 (26.6) 151 (19.4) 348 (25.6) 360 (27.5) 232 (26.3) 434 (24.6) 136 (19.5) 247 (22.8) 545 (27.7)
> 67 483 (10.4) 506 (51.4) 348 (12.9) 153 (16.5) 488 (31.0) 499 (28.5) 196 (16.1) 291 (12.3) 214 (20.4) 304 (23.8) 361 (12.2)
p,p ´-DDE
< LOD or < 33 1,208 (48.1) 80 (10.7) < 0.001 867 (48.7) 255 (36.3) 170 (22.0) < 0.001 233 (27.9) 318 (42.6) 739 (48.1) < 0.001 190 (42.2) 280 (40.3) 740 (45.0)
33–67 1,028 (35.8) 299 (40.1) 683 (36.5) 251 (34.8) 393 (33.4) 404 (35.8) 314 (37.7) 607 (36.1) 202 (32.2) 313 (34.2) 694 (30.0)
> 67 735 (16.0) 555 (48.7) 381 (14.8) 245 (28.9) 664 (40.6) 643 (36.3) 247 (19.7) 398 (15.8) 260 (25.6) 361 (25.5) 520 (17.0)
Oxychlordane 
< LOD 585 (19.0) 16 (1.3) < 0.001 229 (13.8) 112 (18.0) 260 (25.7) < 0.001 193 (17.1) 136 (14.9) 270 (16.7 ) < 0.001 134 (24.7) 167 (19.8) 256 (13.8) < 0.001
< 33 959 (36.6) 36 (3.8) 479 (30.9) 192 (30.4) 324 (35.5) 248 (25.0) 245 (32.4) 501 (33.7) 188 (34.9) 201 (25.2) 529 (33.6)
33–67 804 (32.0) 221 (26.8) 543 (33.7) 183 (27.9) 299 (23.3) 302 (25.3) 242 (32.3) 480 (33.0) 151 (22.7) 242 (27.8) 546 (34.1)
> 67 397 (12.4) 605 (68.1) 514 (21.6) 198 (23.7) 290 (15.5) 451 (32.6) 209 (20.4) 340 (16.6) 159 (17.7) 292 (27.2) 448 (18.5)
trans-Nonachlor
< LOD 318 (9.5) 3 (0.2) < 0.001 128 (6.9) 50 (7.4) 143 (13.8) < 0.001 102 (7.8) 70 (8.4) 149 (8.2) < 0.001 72 (12.9) 82 (8.5) 142 (7.0) < 0.001
< 33 1,144 (39.5) 31 (3.6) 573 (33.5) 213 (30.6) 387 (38.6) 291 (26.8) 281 (32.9) 601 (37.3) 209 (37.3) 26.6 (31.6) 614 (35.3)
33–67 958 (35.3) 252 (30.6) 664 (37.1) 218 (32.0) 328 (26.0) 342 (30.0) 287 (34.8) 580 (36.2) 176 (28.1) 275 (31.2) 659 (37.1)
> 67 534 (15.7) 646 (65.6) 557 (22.5) 264 (30.0) 359 (21.6) 531 (35.4) 245 (23.9) 401 (18.3) 195 (21.6) 326 (28.7) 522 (20.6)
Heptachlor epoxide
< LOD 129 (47.3) 157 (19.2) < 0.001 687 (42.0) 319 (49.5) 447 (44.2) 0.04 410 (40.2) 353 (45.9) 683 (43.0) < 0.001 257 (47.3) 355 (45.4) 729 (42.0) 0.007
< 33 553 (21.6) 140 (15.7) 352 (20.8) 123 (19.2) 218 (21.0) 197 (17.5) 161 (19.5) 334 (22.4) 110 (17.6) 143 (16.1) 379 (23.0)
33–67 507 (18.6) 232 (25.9) 364 (20.2) 112 (15.3) 259 (20.2) 252 (19.1) 156 (18.5) 320 (20.4) 120 (17.0) 184 (17.7) 368 (21.0)
> 67 370 (12.5) 338 (39.2) 356 (17.0) 126 (16.0) 226 (14.6) 316 (23.2) 152 (16.1) 240 (14.2) 133 (18.1) 208 (20.8) 296 (14.0)
Dieldrin
< LOD 567 (26.0) 44 (6.4) < 0.001 268 (21.5) 130 (28.4) 213 (27.3) 0.02 177 (23.5) 147 (25.2) 286 (22.3) 0.06 124 (29.2) 153 (24.7) 301 (21.9) 0.09
< 33 546 (28.0) 110 (17.6) 361 (27.6) 111 (21.8) 184 (25.3) 179 (22.9) 155 (27.3) 320 (27.4) 115 (30.5) 158 (27.3) 338 (25.7)
33–67 518 (27.6) 161 (26.6) 349 (27.3) 139 (26.7) 191 (28.4) 205 (25.5) 141 (25.8) 332 (28.8) 92 (20.7) 158 (26.2) 382 (29.6)
> 67 373 (18.4) 291 (49.4) 368 (23.6) 128 (23.1) 174 (19.0) 242 (28.1) 150 (21.7) 270 (21.5) 97 (19.6) 167 (21.8) 353 (22.8)
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higher exposure to OC pesticides. The associ-
ations between OC pesticides and other cova-
riates including race/ethnicity, family income, 
marital status, and alcohol consumption var-
ied across specific chemicals. 
Table 4 presents the distribution of 
selected characteristics of the 1999–2004 
NHANES adult participants by breast and 
prostate cancer status, respectively. The 
adults who were diagnosed with breast can-
cer were more likely than those without can-
cer to be in the older age group (57.5% vs. 
15.6%, p < 0.001), white (92.6% vs. 69.1%, 
p < 0.001), and of higher income level (68.0% 
vs. 61.0%, p = 0.02). However, there was no 
significant difference in alcohol use, smok-
ing, BMI, and marital status between partici-
pants diagnosed with breast cancer and those 
without cancer. In addition, prostate cancer 
cases were also more likely than those without 
cancer to be older age (85.7% vs. 11.7%), 
white (83.2% vs. 72.1%), and of higher 
income level (97.1% vs. 88.6%). Moreover, 
prostate cancer cases were more likely than 
those without cancer to have a lower educa-
tion level (30.2% vs. 20.6%) and less alcohol 
use (31.6% vs. 16.4%). 
Table 5 shows associations between the 
six selected OC pesticides and the prevalence 
of prostate cancer. We present the results 
from both age-adjusted and multiple variable 
adjusted models. From the age-adjusted model, 
we found that β-HCH, oxychlordane, trans-
nonachlor, and dieldrin showed significant 
trends with the prevalence of prostate cancer 
(all p for trend < 0.05). After adjustment for 
age (< 65 years of age vs. ≥ 65 years), race/eth-
nicity, BMI, education, smoking, NHANES 
data cycle, and marital status, the trends for 
prevalence of prostate cancer remained sig-
nificant for three of six OC pesticides includ-
ing β-HCH, trans-nonachlor, and dieldrin. 
Compared with the reference group, adjusted 
Table 3. Relationships between selected characteristics and OC pesticides (continued).
Chemical (%)
Smoking BMI Marital status Alcohol consumption
Never Former Current p-Value < 25.0 25–29 ≥ 30 p-Value Yes No p-Value Yes No p-Value
β-HCH
< LOD 494 (29.5) 133 (16.5) 249 (30.5) < 0.001 337 (34.8) 279 (24.4) 220 (19.2) < 0.0001 381 (21.9) 471 (33.9) < 0.001 587 (27.6) 224 (22.7) < 0.001
< 33 491 (31.4) 216 (27.4) 269 (35.2) 331 (29.6) 354 (33.4) 292 (31.1) 552 (32.9) 388 (29.3) 710 (34.4) 211 (24.4)
33–67 437 (21.1) 371 (36.8) 218 (23.4) 300 (20.9) 399 (26.8) 325 (29.6) 644 (29.4) 347 (19.6) 694 (25.4) 270 (26.2)
> 67 557 (18.0) 300 (19.3) 131 (10.9) 255 (14.6) 348 (15.4) 382 (20.1) 523 (15.8) 423 (17.2) 514 (12.6) 408 (26.7)
p,p ´-DDE
< LOD or < 33 672 (43.6) 250 (33.7) 368 (49.4) < 0.001 484 (45.6) 422 (42.3) 384 (39.4) < 0.0001 633 (39.2) 612 (47.5) 0.003 905 (45.9) 209 (34.6) < 0.001
33–67 640 (35.1) 380 (40.3) 307 (35.2) 436 (35.3) 492 (37.5) 399 (36.7) 745 (39.3) 526 (32.2) 886 (358) 361 (36.3)
> 67 679 (21.2) 405 (26.0) 205 (15.4) 365 (19.1) 470 (20.2) 450 (23.9) 745 (21.5) 508 (20.3) 743 (17.3) 454 (29.1
Oxychlordane 
< LOD 378 (20.7) 88 (9.3) 134 (14.7) < 0.001 247 (20.4) 193 (15.8) 160 (12.3) 0.001 291 (13.3) 305 (20.5) < 0.001 356 (15.0) 192 (19.0) < 0.001
< 33 526 (31.4) 213 (28.5) 255 (35.4) 341 (32.2) 353 (30.8) 300 (30.9) 546 (31.0) 443 (32.7) 688 (35.9) 233 (24.6)
33–67 468 (29.4) 302 (32.8) 255 (33.4) 300 (28.8) 371 (32.2) 304 (33.1) 617 (33.9) 398 (27.6) 712 (32.7) 258 (28.5)
> 67 477 (18.5) 355 (29.4) 169 (16.4) 281 (17.7) 376 (21.2) 341 (23.7) 547 (21.8) 438 (19.2) 587 (18.4) 360 (27.9)
trans-Nonachlor
< LOD 205 (10.1) 37 (4.2) 78 (3.1) < 0.001 134 (10.0) 103 (7.5) 83 (6.6) < 0.001 135 (5.6) 176 (12.1) < 0.001 197 (7.7) 103 (9.6) < 0.001
< 33 665 (36.6) 221 (26.8) 288 (36.5) 433 (37.1) 309 (32.7) 352 (32.1) 643 (34.2) 429 (34.8) 787 (35.9) 303 (28.1)
33–67 554 (32.5) 358 (37.5) 298 (35.9) 360 (31.4) 431 (34.9) 418 (38.1) 697 (36.6) 458 (30.6) 827 (35.8) 304 (31.8)
> 67 561 (20.8) 408 (31.5) 210 (19.5) 349 (21.4) 455 (24.8) 372 (23.2) 630 (23.6) 507 (22.5) 709 (20.6) 407 (30.5)
Heptachlor epoxide
< LOD 791 (46.1) 292 (33.8) 368 (46.9) < 0.001 666 (60.6) 400 (39.9) 304 (26.8) < 0.001 732 (38.7) 711 (49.2) 0.002 944 (43.1) 399 (42.2) < 0.001
< 33 337 (19.0) 195 (23.6) 161 (21.2) 203 (16.9) 273 (24.1) 216 (26.8) 406 (21.9) 286 (19.3) 480 (22.2) 168 (16.0)
33–67 339 (18.2) 238 (23.2) 158 (18.6) 155 (11.7) 288 (21.2) 290 (26.9) 447 (22.2) 282 (16.2) 507 (20.5) 184 (18.4)
> 67 359 (16.6) 227 (19.4) 121 (13.3) 142 (10.8) 236 (14.8) 329 (25.0) 395 (17.2) 295 (15.3) 402 (14.2) 272 (23.4)
Dieldrin
< LOD 325 (23.6) 122 (19.6) 164 (26.1) 0.004 303 (31.4) 203 (21.0) 103 (10.5) < 0.001 317 (20.8) 294 (26.6) 0.20 400 (23.6) 169 (23.1) 0.01
< 33 331 (25.8) 151 (24.3) 173 (29.8) 243 (29.1) 245 (28.2) 166 (21.8) 361 (27.4) 295 (25.4) 429 (26.4) 186 (27.2
33–67 324 (28.2) 194 (27.9) 161 (25.7) 182 (22.0) 232 (26.3) 264 (34.9) 388 (27.8) 291 (27.0) 473 (28.4) 159 (23.3)
> 67 329 (22.4) 215 (28.2) 125 (18.4) 135 (12.5) 241 (24.5) 293 (32.8) 385 (24.0) 285 (21.0) 420 (21.6) 210 (26.4)
Abbreviations: NHB, non-Hispanic black; NHW, non-Hispanic white.
Table 4. Distribution of selected characteristics by cancer status among the 1999–2004 NHANES adult 
participants ≥ 20 years of age [no. (%)]. 
Breast cancer Prostate cancer
Characteristic Cases Noncases p-Value Cases Noncases p-Value
Age (years)
< 65 21 (42.5) 1,701 (84.4) < 0.0001 7 (14.3) 1,492 (88.3) < 0.001
≥ 65 41 (57.5) 488 (15.6) 58 (85.7) 428 (11.7)
Race 
Non-Hispanic white 52 (92.6) 1,033 (69.1) < 0.001 46 (83.2) 948 (72.1) 0.02
Non-Hispanic black 7 (6.7) 437 (12.4) 13 372 (10.5)
Others 3 (0.7) 719 (18.5) 6 (6.1) 600 (17.4)
Education
< High school  17 (21.8) 693 (20.0) 0.19 26 (30.2) 650 (20.6) < 0.001
High School  19 (35.7) 502 (24.8) 13 (22.9) 426 (24.6)
> High school 26 (42.5) 991 (55.1) 26 (46.8) 841 (54.8)
Poverty/income ratio 
< 1.0 5 (5.5) 410 (16.2) 0.02 3 (2.9) 300 (11.4) < 0.001
1.0–2.0 17 (26.5) 538 (22.8) 16 (28.4) 460 (20.1)
> 2.0 36 (68.0) 1,037 (61.0) 39 (68.7) 989 (68.4)
Smoking 
Never 31 (47.8) 1,327 (56.7) 0.20 26 (39.1) 797 (42.7) 0.006
Former 25 (38.3) 474 (21.8) 31 (50.1) 585 (27.3)
Current 6 (13.9) 387 (21.5) 7 (10.8) 537 (30.0)
BMI 
< 25.0  24 (39.8) 747 (37.9) 0.51 20 (25.5) 605 (31.7) 0.41
25–29 22 (28.7) 667 (36.7) 30 (48.8) 778 (38.9)
≥ 30 16 (31.5) 769 (25.4) 15 (25.7) 535 (29.4)
Marital status
Yes 23 (43.6) 1,107 (55.2) 0.21 44 (70.0) 1,116 (61.0) 0.11
No 38 (56.4) 1,001 (44.8) 20 (30.0) 744 (39.0)
Alcohol consumption 
Yes 39 (68.3) 1,123 (61.2) 0.39 45 (68.4) 1,499 (83.6) 0.04
No 22 (31.7) 876 (38.8) 17 (31.6) 311 (16.4)Xu et al.
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ORs for the second and the third tertiles 
(respectively) were 1.46 (95% CI, 0.52–4.13) 
and 3.36 (95% CI, 1.24–9.10) for β-HCH 
(p for trend = 0.02); 5.84 (95% CI, 1.06–32.2) 
and 14.1 (95% CI, 2.55–77.9) for trans-
  nonachlor; and 1.06 (95% CI, 0.30–3.73) and 
2.74 (95% CI, 1.01–7.49) for dieldrin. 
We also examined the associations 
between prevalence of breast cancer with 
these six chemicals. However, none of the 
OC pesticides were found to be significantly 
associated with prevalence of breast cancer 
in age-adjusted models or multiple variable 
adjusted models, which included the covari-
ates of age (< 65 years of age vs. ≥ 65 years), 
race/ethnicity, BMI, education, smoking, 
NHANES data cycle, and marital status. 
The results are presented in Table 6. We also 
considered other covariates including alco-
hol use, age at menarche, menopausal status, 
parity, age at first full-term birth or nulli-
parity, breast-feeding, oral contraceptive use, 
and hormone replacement therapy use in the 
adjusted models. However, the results did not 
appreciably change with further adjustment 
for these variables other than increasing the 
uncertainty of the estimation. The data are 
not presented.
Discussion
Several studies have suggested that OC pes-
ticides may modulate steroid sex hormones 
such as estrogen or testosterone as agonists or 
antagonists or as mixed effects (Sonnenschein 
and Soto 1998). Because some cancers 
(including those of the breast and prostate) 
are hormone-dependent, research has been 
focused on the potential risk associated with 
OC pesticides exposures (Ejaz et al. 2004). 
In this study, we examined the associations 
between OC pesticides and prostate cancer 
as well as breast cancer. This cross-sectional 
study demonstrated that background expo-
sure to OC pesticides was positively associ-
ated with the prevalence of prostate cancer 
in the U.S. general population. The associa-
tions were consistently in the same direction, 
although the details of associations were sub-
stantially different depending on the specific 
subclass of OC pesticides. 
Other epidemiologic studies have also sug-
gested an association between prostate cancer 
and OC pesticides. Our findings are in gen-
eral agreement with, but stronger than, those 
of previous epidemiologic studies. Several 
occupational cohort studies and case–control 
studies have found OC pesticides to be associ-
ated with an increased risk of prostate can-
cer (Dich and Wiklund 1998; Fleming et al. 
1999; Ritchie et al. 2003; Settimi et al. 2003). 
However, some studies have not observed 
similar associations (Mozzachio et al. 2008; 
Wiklund et al. 1989). Thus, although our 
study adds to the growing evidence that OC 
exposure is associated with cancer prevalence, 
additional studies are necessary. 
Although we observed a significant asso-
ciation between OC pesticides and pros-
tate cancer prevalence, we did not observe 
an association with breast cancer prevalence. 
Although a few studies support the associa-
tion between breast cancer and OC pesticide 
(Charlier et al. 2003; Wolff et al. 1993), the 
vast majority of epidemiologic studies do not 
(Ward et al. 2000; Wolff et al. 2000; Zheng 
et al. 2000). Overall, there is not overwhelm-
ing evidence that suggests that exposure to 
OC pesticide is associated with breast cancer 
(Calle et al. 2002). 
Our study had some important design fea-
tures that strengthen confidence in its results: 
First, we found considerable differences of the 
proportions of at or above LOD in the differ-
ent data cycles for those pesticides that have a 
low proportion of values above the LOD (i.e., 
below 50%) in Table 1. One possible explana-
tion could be that these pesticides with a very 
low proportion of values above the LOD are 
more sensitive to measurement errors intro-
duced during sample collection, storage, prepa-
ration, and testing. Moreover, for the same OC 
pesticide, the detection limit varies by indi-
vidual. The larger the serum volume, the lower 
the detection limits are. Therefore, the different 
study population sample and the volume of 
blood sample collected from each participant 
might also contribute to the variation of the 
percentage above the LOD in different years. 
To minimize nondifferential measurement 
error, we selected those OC pesticides that 
had at least 50% of study subjects with serum 
concentration above the LOD. Second, serum 
levels of individual OC pesticides represent 
surrogate measurements of long-term expo-
sure. This methodology is regarded as the most 
effective way of assessing exposure to these 
chemicals, (i.e., lipophilic, resistant to metabo-
lism, and stored in adipose tissue) (Barr 2008). 
Most previous studies have focused on highly 
selected populations such as a specific occupa-
tional group. The exposure pattern and dose 
of OC pesticides from occupational sites may 
be different from background exposures expe-
rienced by the general population. It has been 
shown that OC measurements in the blood of 
occupational populations may be 1–3 orders of 
magnitude higher than blood levels measured 
in the general population (Liem et al. 2000). 
However, few studies of OC pesticides have 
been carried out in the general population, 
even in a cross-sectional design, because of the 
high cost of collecting blood samples and the 
wide variation of OC pesticides or metabo-
lites. Therefore, the NHANES data provided 
a unique chance to investigate the possible 
associations between serum concentrations of 
Table 5. Lipid-adjusted serum concentration (ng/g) and prevalent prostate cancer in 1999–2004 NHANES 
adult participants, by tertile.
Chemical
Not detectable Detectable
ptrend < LOD < 33rd 33rd –67th > 67th
β-HCH
Median concentration — 6.2 16.2 53.9
Cases/no. 5/453 9/528 23/531 21/307
Age-adjusted OR (95% CI) 1.0 1.0 1.44 (0.55–3.78) 3.10 (1.36–7.11) 0.007
Adjusted OR (95% CI)a 1.0 1.0 1.46 (0.52–4.13) 3.36 (1.24–9.10) 0.02
p,p ´-DDE
Median concentration — 113.0 386.0 1530.0
Cases/no. 0/3 8/599 28/692 23/547
Age-adjusted OR (95% CI) 1.0 1.0 1.89 (0.71–5.04) 2.02 (0.76–5.32) 0.16
Adjusted OR (95% CI)a 1.0 1.0 2.05 (0.76–5.50) 2.64 (0.92–7.57) 0.07
Oxychlordane 
Median concentration  — 8.0 17.2 37.0
Cases/no. 0/273 5/488 19/506 29/441
Age-adjusted OR (95% CI) 1.0 1.0 3.38 (1.02–11.3) 3.39 (1.03–11.1) 0.04
Adjusted OR (95% CI)a 1.0 1.0 3.54 (0.91–13.8) 3.54 (0.92–13.6) 0.06
Trans-nonachlor
Median concentration  — 9.9 24.8 56.4
Cases/no. 0/154 3/521 12/571 41/582
Age-adjusted OR (95% CI) 1.0 1.0 4.76 (1.13–20.1) 9.51 (2.22–40.8) 0.002
Adjusted OR (95% CIa 1.0 1.0 5.84 (1.06–32.2) 14.1 (2.55–77.9) 0.002
Heptachlor epoxide
Median concentration — 5.0 8.9 18.0
Cases/no. 10/681 7/339 12/360 21/311
Age-adjusted OR (95% CI) 1.0 0.68 (0.20–2.29) 1.39 (0.57–3.34) 1.79 (0.59–5.47) 0.15
Adjusted OR (95% CI)a 1.0 1.01 (0.31–3.20) 1.65 (0.73–3.76) 1.91 (0.70–5.33) 0.12
Dieldrin
Median concentration  — 4.8 7.9 14.7
Cases/no. 0/257 6/286 6/362 25/343
Age-adjusted OR (95% CI) 1.0 1.0 0.98 (0.31–3.08) 2.69 (1.09–6.68) 0.03
Adjusted OR (95% CI)a 1.0 1.0 1.06 (0.30–3.73) 2.74 (1.01–7.49) 0.04
aAdjusted for age, race, and ethnicity, BMI, education, smoking, data cycle, and marital status.OC pesticides and cancer
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individual OC pesticides and hormone-related 
cancers in a representative sample of the general 
population. Finally, the NHANES data pro-
vided information regarding a variety of poten-
tially confounding factors such as demographic 
characteristics, socioeconomic status, lifestyle 
factors, and physical measurements. Thus, we 
were able to control for the confounding effects 
of these factors in our analyses. 
Nevertheless, this study also has several 
limitations. The findings from this study 
should be interpreted with caution because 
of the nature of a cross-sectional study design, 
despite both the magnitude of association 
and the dose–response relationship. OC pes-
ticides display high resistance to degradation. 
Although the persistence of DDE, β-HCH, 
chlordane, heptachlor epoxide, and dieldrin 
in the environment varies by climate, these 
chemicals may persist in soil for a period rang-
ing from a few years to decades. For example, 
the half-life of DDE in soil may be more than 
20 years (Agency for Toxic Substances and 
Disease Registry 2002). Biological half-lives 
of several years have been reported in humans 
for these chemicals (Morgan and Roan 1971). 
Thus, it is possible that these chemicals could 
be stored in human body fat for a long time. 
Furthermore, because these chemicals are 
stored in fat, it is believed that adipose tis-
sue loss could result in increased organ and 
blood concentrations of these compounds 
(Hue et al. 2006). Several studies suggested 
that weight loss may be associated with an 
increase in serum concentrations of OCs 
because of bioconcentration (Chevrier et al. 
2000; Imbeault et al. 2002). Thus, if changes 
in body weight occur as a consequence of the 
development of cancers, the cross-sectional 
findings in this study may reflect reverse cau-
sality. We examined the correlations between 
time since cancer diagnosis and serum con-
centrations of OC pesticides to see if any clear 
pattern emerged that would indicate that can-
cer-related weight loss over time may be asso-
ciated with OC concentrations. The results 
indicated that there was no association. In 
addition, body fat is an important risk factor 
for breast cancer and prostate cancer (Cleary 
and Grossmann 2009; Hsing et al. 2007). 
Although we adjusted for BMI in our analy-
ses, BMI as a measure of body fat has certain 
limitations. It does not account for skeletal 
size, muscle mass, amount of body water, 
and the effect of sex (Charbonneau-Roberts 
et al. 2005). Therefore, additional measures 
of body fat, such as waist-to-hip ratio, should 
be considered in future studies. In addition, 
all cancers in this study were prevalent cancer 
cases, which could introduce survival bias. 
Although survival bias may be a concern, 
there is some evidence that OC pesticides also 
have adverse effects on cancer survival (Hoyer 
et al. 2000, 2001). Under such circumstances, 
we would expect survival bias to bias our esti-
mates toward the null. Additionally, previous 
studies have reported that Mexican Americans 
have higher OC pesticide levels than the rest 
of the population (Bradman et al. 2007). 
Because of the limited number of cancer cases 
in this analysis, particu  larly among Hispanics, 
it was not possible to specifically examine 
the relationship between OC pesticides and 
prostate and breast cancers within this sub-
population. Moreover, measurement errors 
in exposures, covariates, and health outcomes 
are also of concern. Measurement errors in 
blood OC pesticides could stem from with-
in-person variation of serum concentrations 
of OC pesticides and potential errors dur-
ing sampling, storage, analysis of biological 
specimens, and data processing. Additionally, 
information regarding both health outcomes 
and covariates largely relied on self-reported 
data. Reliance on self-reported data in the 
measurement of both the dependent variables 
and some covariates raised concerns about 
the validity of causal conclusions for a range 
of reasons, including systematic response 
distortions and method variance (Mackay 
et al. 2007). Furthermore, the observed asso-
ciations are potentially confounded by those 
unmeasured factors such as family history, 
previous dietary information, and previ-
ous physical activities. Finally, although the 
cohort as a whole provides adequate power 
to examine our primary research questions, 
the sample sizes within cancer case groups 
are relatively small. Consequently, there are 
relatively wide CIs of the estimations after 
accounting for multiple risk factors. 
Conclusion
Our analysis of the 1999–2004 NHANES 
data suggests that serum concentrations of 
OC pesticides were positively associated 
with hormone-related cancer as a group and 
with prostate cancer specifically in this sam-
ple of the U.S. population. Future studies 
should consider maximizing the case sample, 
improving the data quality by minimizing 
the proportion of missing data, increasing the 
information accuracy, and collecting addi-
tional information such as genetic factors, 
which may increase the value of the NHANES 
data sets to better address these questions. 
Because these findings are based on survey 
data with limited control over the meas-
urement of variables, we suggest that exami-
nation of these relationships warrants further 
study. Importantly, prospective follow-up of 
cancer cases should be considered to address 
some of the methodologic concerns noted 
in this article, such as cancer-related weight 
loss and OC concentrations, in addition to 
exploring the effects of OC concentrations on 
Table 6. Lipid-adjusted serum concentration (ng/g) and prevalent breast cancer in 1999–2004 NHANES 
adult participants, by tertile.
Not detectable Detectable
Chemical < LOD < 33rd 33rd –67th > 67th ptrend
β-HCH
Median concentration — 6.2 16.2 53.9
Cases/no. 2/424 5/449 23/495 25/682
Age-adjusted OR (95% CI) 1.0 1.0 2.84 (0.79–10.2) 1.67 (0.42–6.54) 0.46
Adjusted OR (95% CI)a 1.0 1.0 2.82 (0.75–10.65) 2.33 (0.53–10.33) 0.26
p,p ´-DDE
Median concentration — 113.0 386.0 1530.0
Cases/no. 0/1 9/689 20/635 26/743
Age-adjusted OR (95% CI) 1.0 1.0 1.24 (0.48–3.19) 0.93 (0.34–2.56) 0.88
Adjusted OR (95% CI)a 1.0 1.0 1.26 (0.49–3.27) 1.19 (0.40–3.50) 0.76
Oxychlordane 
Median concentration  — 8.0 17.2 37.0
Cases/no. 2/328 3/507 18/519 28/561
Age-adjusted OR (95% CI) 1.0 1.0 4.25 (1.25–14.4) 2.97 (0.88–10.0) 0.08
Adjusted OR (95% CI)a 1.0 1.0 3.68 (1.12–12.13) 2.55 (0.73–8.83) 0.14
Trans-nonachlor
Median concentration  — 9.9 24.8 56.4
Cases/no. 1/167 4/654 21/639 29/598
Age-adjusted OR (95% CI) 1.0 1.0 3.29 (0.96–11.3) 2.66 (0.63–11.2) 0.18
Adjusted OR (95% CI)a 1.0 1.0 2.80 (0.81–9.67) 2.60 (0.65–10.35)
Heptachlor epoxide
Median concentration  — 5.0 8.9 18.0
Cases/no. 12/772 16/354 11/375 13/397
Age-adjusted OR (95% CI) 1.0 2.75 (1.26–5.99) 1.14 (0.46–2.84) 1.19 (0.50–2.83) 0.79
Adjusted OR (95% CI)a 1.0 2.21 (1.01–4.83) 1.05 (0.36–3.05) 1.08 (0.40–2.93) 0.74
Dieldrin
Median concentration  — 4.8 7.9 14.7
Cases/no. 5/354 16/370 12/317 10/327
Age-adjusted OR (95% CI) 1.0 2.18 (0.83–5.76) 1.23 (0.38–4.02) 1.01 (0.30–3.41) 0.78
Adjusted OR (95% CI)a 1.0 2.28 (0.76–6.87) 1.21 (0.34–4.29) 1.04 (0.26–4.16) 0.81
aAdjusted for age, race, and ethnicity, BMI, education, smoking, data cycle, and marital status.Xu et al.
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survival. Therefore, prospective studies of the 
relation between background pesticide expo-
sure and validated cancer diagnoses should be 
a priority in future studies. Despite the con-
troversial and complex issues involved with 
continued OC use, efforts to improve cancer 
surveillance, early detection, and access to 
appropriate treatments should be considered 
in countries where OC pesticide use remains 
common.
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